11-5697266-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006074.5(TRIM22):āc.442C>Gā(p.Leu148Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,612,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006074.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIM22 | NM_006074.5 | c.442C>G | p.Leu148Val | missense_variant | 3/8 | ENST00000379965.8 | NP_006065.2 | |
TRIM22 | NM_001199573.2 | c.442C>G | p.Leu148Val | missense_variant | 3/8 | NP_001186502.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIM22 | ENST00000379965.8 | c.442C>G | p.Leu148Val | missense_variant | 3/8 | 1 | NM_006074.5 | ENSP00000369299 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 247188Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134180
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460474Hom.: 0 Cov.: 29 AF XY: 0.00000551 AC XY: 4AN XY: 726422
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2024 | The c.442C>G (p.L148V) alteration is located in exon 3 (coding exon 2) of the TRIM22 gene. This alteration results from a C to G substitution at nucleotide position 442, causing the leucine (L) at amino acid position 148 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at